Clinical Trial Update: Quality Of Life While Receiving Faslodex

View source ↗

Summary

A completed clinical trial update reporting on quality of life for patients with breast cancer receiving Faslodex (fulvestrant).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Faslodex (fulvestrant)

Snippet

Sponsor: AstraZeneca | Conditions: Breast Cancer | Status: COMPLETED